BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32628466)

  • 1. Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer.
    Martínez-Carmona M; Ho QP; Morand J; García A; Ortega E; Erthal LCS; Ruiz-Hernandez E; Santana MD; Ruiz J; Vallet-Regí M; Gun'ko YK
    Inorg Chem; 2020 Jul; 59(14):10275-10284. PubMed ID: 32628466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
    Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
    Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diatom-like silica-protein nanocomposites for sustained drug delivery of ruthenium polypyridyl complexes.
    Shi H; Lou J; Lin S; Wang Y; Hu Y; Zhang P; Liu Y; Zhang Q
    J Inorg Biochem; 2021 Aug; 221():111489. PubMed ID: 34000586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
    Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
    ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of an anticancer organoruthenium complex as the guest and polydiacetylene-coated fluorogenic nanocarrier as the host: engineering nanocarrier using ene-yne conjugation for sustained guest release, enhanced anticancer activity and reduced
    Sumithaa C; Gajda-Morszewski P; Ishaniya W; Khamrang T; Velusamy M; Bhuvanesh N; Brindell M; Mazuryk O; Ganeshpandian M
    Dalton Trans; 2024 Jan; 53(3):966-985. PubMed ID: 38054338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Anticancer Activity of an Electron-Deficient Organoruthenium(II) Complex.
    Soldevila-Barreda JJ; Azmanova M; Pitto-Barry A; Cooper PA; Shnyder SD; Barry NPE
    ChemMedChem; 2020 Jun; 15(11):982-987. PubMed ID: 32237195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium-loaded mesoporous silica as tumor microenvironment-response nano-fenton reactors for precise cancer therapy.
    Sun D; Wang Z; Zhang P; Yin C; Wang J; Sun Y; Chen Y; Wang W; Sun B; Fan C
    J Nanobiotechnology; 2021 Apr; 19(1):98. PubMed ID: 33827604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles functionalised with a photoactive ruthenium(ii) complex: exploring the formulation of a metal-based photodynamic therapy photosensitiser.
    Ellahioui Y; Patra M; Mari C; Kaabi R; Karges J; Gasser G; Gómez-Ruiz S
    Dalton Trans; 2019 May; 48(18):5940-5951. PubMed ID: 30209497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trans-[Ru(PPh
    Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
    J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
    Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium complex delivery using liposomes to improve bioactivity against HeLa cells via the mitochondrial pathway.
    Guo B; Liao C; Fang Y; Li S; Li X; Lu Z; Chen Y
    Nanomedicine (Lond); 2018 Nov; 13(22):2851-2866. PubMed ID: 30457036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
    Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
    Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone H2A-peptide-hybrided upconversion mesoporous silica nanoparticles for bortezomib/p53 delivery and apoptosis induction.
    Rong J; Li P; Ge Y; Chen H; Wu J; Zhang R; Lao J; Lou D; Zhang Y
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110674. PubMed ID: 31855686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
    Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
    J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of [Ru(η
    Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
    J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
    Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
    Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
    J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.